Emily T. Martin

16.6k total citations · 3 hit papers
208 papers, 5.7k citations indexed

About

Emily T. Martin is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emily T. Martin has authored 208 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Epidemiology, 85 papers in Infectious Diseases and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emily T. Martin's work include Respiratory viral infections research (113 papers), Influenza Virus Research Studies (91 papers) and SARS-CoV-2 and COVID-19 Research (29 papers). Emily T. Martin is often cited by papers focused on Respiratory viral infections research (113 papers), Influenza Virus Research Studies (91 papers) and SARS-CoV-2 and COVID-19 Research (29 papers). Emily T. Martin collaborates with scholars based in United States, Israel and Kenya. Emily T. Martin's co-authors include Janet A. Englund, Arnold S. Monto, Jane Kuypers, Annemarie Mol, Ryan E. Malosh, Joshua G. Petrie, Keith S. Kaye, Anna Wald, Adam S. Lauring and Danielle M. Zerr and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Emily T. Martin

193 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis

2015 403 citations Emily T. Martin, Keith S. Kaye et al. profile →
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries

2022 127 citations Emily T. Martin et al. profile →
Wastewater-Based Detection of Two Influenza Outbreaks

2022 116 citations Lindsey Mortenson, Adam S. Lauring et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily T. Martin United States	39	3.3k	2.3k	646	520	385	208	5.7k
Ping‐Ing Lee Taiwan	43	3.0k 0.9×	2.8k 1.2×	652 1.0×	859 1.7×	236 0.6×	238	7.0k
Joon Young Song South Korea	36	3.2k 1.0×	1.7k 0.8×	310 0.5×	329 0.6×	310 0.8×	301	5.6k
Douglas Fleming United Kingdom	51	5.4k 1.6×	1.4k 0.6×	799 1.2×	386 0.7×	807 2.1×	158	8.0k
Tony Mazzulli Canada	46	3.4k 1.0×	1.8k 0.8×	339 0.5×	341 0.7×	155 0.4×	232	6.9k
James G. Donahue United States	35	2.7k 0.8×	1.4k 0.6×	496 0.8×	629 1.2×	132 0.3×	100	5.9k
Janet Raboud Canada	45	2.7k 0.8×	3.2k 1.4×	571 0.9×	708 1.4×	127 0.3×	238	7.1k
Stephanie R. Bialek United States	35	3.3k 1.0×	2.2k 1.0×	331 0.5×	338 0.7×	493 1.3×	86	6.4k
Jonathan S. Nguyen‐Van‐Tam United Kingdom	44	3.5k 1.1×	2.8k 1.2×	998 1.5×	325 0.6×	858 2.2×	168	7.5k
Nancy M. Bennett United States	45	8.5k 2.6×	1.2k 0.5×	511 0.8×	501 1.0×	275 0.7×	126	10.4k
Thomas Hanslik France	31	1.6k 0.5×	813 0.4×	1.0k 1.6×	321 0.6×	298 0.8×	197	4.4k

Countries citing papers authored by Emily T. Martin

Since Specialization

Citations

This map shows the geographic impact of Emily T. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily T. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily T. Martin more than expected).

Fields of papers citing papers by Emily T. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily T. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily T. Martin. The network helps show where Emily T. Martin may publish in the future.

Co-authorship network of co-authors of Emily T. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Emily T. Martin. A scholar is included among the top collaborators of Emily T. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily T. Martin. Emily T. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lewis, Nathaniel M., H. Keipp Talbot, Yuwei Zhu, et al.. (2025). Severity of Clinical Presentation and Outcomes in Hospitalized Adult People With Influenza by Type and Subtype, United States—2017–2020. Clinical Infectious Diseases. 82(3). e580–e588.

Monto, Arnold S., Amy P. Callear, Aleda M. Leis, et al.. (2024). Respiratory Viral Infections From 2015 to 2022 in the HIVE Cohort of American Households: Incidence, Illness Characteristics, and Seasonality. The Journal of Infectious Diseases. 231(3). 795–804. 6 indexed citations

Sandford, Ryan, Kelsey M. Sumner, Sara Y. Tartof, et al.. (2024). Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022. Influenza and Other Respiratory Viruses. 18(7). e13339–e13339.

Lewis, Nathaniel M., Miranda J. Delahoy, Kelsey M. Sumner, et al.. (2023). Risk factors for infection with influenza A(H3N2) virus on a US university campus, October–November 2021. Influenza and Other Respiratory Viruses. 17(5). e13151–e13151. 1 indexed citations

Flannery, Brendan, H. Keipp Talbot, Carlos G. Grijalva, et al.. (2022). Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season. Clinical Infectious Diseases. 76(8). 1358–1363. 32 indexed citations

Jackson, Michael L., C. Hallie Phillips, Erika Kiniry, et al.. (2022). Burden of medically attended influenza infection and cases averted by vaccination – United States, 2016/17 through 2018/19 influenza seasons. Vaccine. 40(52). 7703–7708. 2 indexed citations

Petrie, Joshua G., et al.. (2021). Agreement between state registry, health record, and self-report of influenza vaccination. Vaccine. 39(38). 5341–5345. 6 indexed citations

Blostein, Freida, et al.. (2021). Associations Between Salivary Bacteriome Diversity and Salivary Human Herpesvirus Detection in Early Childhood: A Prospective Cohort Study. Journal of the Pediatric Infectious Diseases Society. 10(8). 856–863. 1 indexed citations

Malosh, Ryan E., Joshua G. Petrie, Amy P. Callear, et al.. (2021). Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?. Clinical Infectious Diseases. 73(7). 1248–1256. 11 indexed citations

10.

DeJonge, Peter M., Arnold S. Monto, Ryan E. Malosh, et al.. (2021). Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan. Influenza and Other Respiratory Viruses. 16(3). 521–531. 4 indexed citations

11.

Petrie, Joshua G., Latifa A. Bazzi, Adrian B. McDermott, et al.. (2021). Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses. The Journal of Infectious Diseases. 224(1). 49–59. 20 indexed citations

12.

Balasubramani, G.K., Mary Patricia Nowalk, Theresa M. Sax, et al.. (2020). Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016. Influenza and Other Respiratory Viruses. 14(4). 380–390. 7 indexed citations

13.

Baang, Ji Hoon, Christopher Smith, Carmen Mirabelli, et al.. (2020). Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient. The Journal of Infectious Diseases. 223(1). 23–27. 185 indexed citations

14.

Brouwer, Andrew F., Jeffrey L. Myers, Emily T. Martin, et al.. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance in Decedents in a Large, Urban Medical Examiner’s Office. Clinical Infectious Diseases. 72(10). e580–e585. 6 indexed citations

15.

Chung, Jessie R., Sara Kim, Michael L. Jackson, et al.. (2020). Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2. Open Forum Infectious Diseases. 8(1). ofaa576–ofaa576. 7 indexed citations

16.

McCormick, Kevin D., Megan E. Gumina, Joshua G. Petrie, et al.. (2018). Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo. Journal of Virology. 92(19). 13 indexed citations

17.

Jackson, Michael L., Jessie R. Chung, Lisa A. Jackson, et al.. (2017). Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season. New England Journal of Medicine. 377(6). 534–543. 194 indexed citations

18.

Kilgore, Paul E., Richard B. Evans, Keith S. Kaye, et al.. (2017). Survey of vaccination knowledge and acceptance among adults admitted to an urban emergency department. Vaccine. 35(8). 1148–1151. 6 indexed citations

19.

Martin, Emily T., Jane Kuypers, John P. McRoberts, Janet A. Englund, & Danielle M. Zerr. (2015). Human Bocavirus 1 Primary Infection and Shedding in Infants. The Journal of Infectious Diseases. 212(4). 516–524. 84 indexed citations

20.

Gravett, Courtney, Michael G. Gravett, Emily T. Martin, et al.. (2012). Serious and Life-Threatening Pregnancy-Related Infections: Opportunities to Reduce the Global Burden. PLoS Medicine. 9(10). e1001324–e1001324. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact